Impact of Tensor Fascia Lata Stretch on Vastus Medialis Obliqus Activity
Launched by AHRAM CANADIAN UNIVERSITY · Dec 14, 2024
Trial Information
Current as of April 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific stretching exercise on a muscle in the thigh called the Vastus Medialis Obliquus (VMO). The participants will have a common knee condition known as patellofemoral pain syndrome (PFPS), which causes pain in the front of the knee, especially during activities like running, jumping, or sitting for long periods. The goal is to see if stretching a muscle on the side of the hip can help improve the way the VMO and another thigh muscle work together, potentially reducing knee pain.
This study is currently looking for participants who are between 18 and 30 years old, experience non-injury-related knee pain, and have some difficulty with activities like squatting or going up and down stairs. However, individuals with certain knee conditions, previous surgeries, or specific health issues may not be eligible. If you join the trial, you can expect to perform some exercises and possibly learn more about managing your knee pain with guidance from the research team. Your participation could help improve treatment options for young people with knee pain in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Both genders.
- • 2. Body mass index (BMI) ranges from 18.5 to 29.9.
- • 3. Age ranges between 18 and 30 years old.
- • 4. Experience nontraumatic anterior knee pain.
- • 5. Pain with any two activities, including running, jumping, squatting, kneeling, stair ascent/descent or prolonged sitting.
- • 6. Having at least one positive PFPS clinical tests including, patellofemoral compression, patellofemoral gliding or resistive quadriceps setting
- Exclusion Criteria:
- • 1. Coexisting pathology around the knee, including patellar subluxation or dislocation.
- • 2. Previous knee surgery.
- • 3. Suspicion of patellar tendinopathy, with strong consideration of pain localised to the patellar tendon.
- • 4. Patients didn't receive physiotherapy treatment or use of non-steroidal anti-inflammatory drugs for knee pain in the previous 3 months.
- • 5. Any neurological or rheumatic disorders
- • 6. Pain intensity more than 5 (based on visual analogue scale)
- • 7. Hip and ankle pathology.
- • 8. BMI more than 30%.
- • 9. Pregnancy.
About Ahram Canadian University
Ahram Canadian University is a distinguished educational institution committed to advancing research and innovation in the field of healthcare. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct rigorous research studies that contribute to the understanding of medical treatments and interventions. By fostering collaboration among researchers, healthcare professionals, and industry partners, Ahram Canadian University aims to enhance patient outcomes and drive the development of evidence-based practices in medicine. Through its commitment to ethical standards and scientific integrity, the university plays a pivotal role in shaping the future of healthcare research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Enas Fawzy, Professor
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported